Clinical Trials Browser

Phase 2 × Adenoma, Islet Cell × nimotuzumab × Clear all

NCT05316480 2022-04-07

Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms

Phase 2 Not yet recruiting

Adenoma, Islet Cell